Related Experiment Video
Updated: Sep 14, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Clinical Phenotype Spectrum in Two Large Chinese Families With Rippling Muscle Disease Caused by CAV-3 c.80G>A
Yu Shen1, Kaiyan Jiang1, Hancun Yi1
1Department of Neurology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Abstract:
Rippling muscle disease (RMD) is a rare benign myotonic myopathy caused by pathogenic variants in the caveolin-3 (CAV-3) gene and is characterized by highly irritable muscles, transient localized muscle bulges, and ripple-like contractions. There is still a lack of systematic understanding of the phenotypic spectrum of RMD. In this study, clinical data were collected from patients with RMD. The analysis of the pathogenic variants in the CAV-3 gene was conducted by next-generation sequencing and Sanger sequencing. Changes in the expression of the CAV3 protein were analyzed by immunohistochemistry and western blotting. In addition, we performed a literature review of previously reported RMD patients. A total of 12 patients with RMD were clinically diagnosed in two families. All patients presented with childhood-onset exercise intolerance, muscle stiffness, and myalgia after exercise. Percussion-induced rapid muscle mounding and contractions were observed in all patients. Electromyography revealed myogenic damage in Patient 1 and Patient 2. Muscle MRI of the thigh and leg suggested mild muscle atrophy in Patient 2. Muscle pathology revealed nonspecific myopathy-like changes in Patient 2. A heterozygous variant c.80G>A (p.Arg27Gln) in the CAV3 gene was identified in all patients with RMD. Immunohistochemical and western blot analyses revealed reduced expression of the CAV3 protein in muscle tissue. These results demonstrated the clinical, electromyographical, and pathological features of RMD patients in two large Chinese families, with reviewing the literature, provide a better understanding of the variable RMD phenotypes. Trial Registration: SJNKHDJ20221213160659.
Insights
Rippling muscle disease (RMD), a myotonic myopathy linked to CAV-3 gene variants, presents with exercise intolerance and muscle issues. This study details RMD phenotypes in Chinese families, enhancing understanding of this rare condition.
Area of Science:
- Neurology
- Genetics
- Muscle Diseases
Background:
- Rippling muscle disease (RMD) is a rare myotonic myopathy.
- It is caused by pathogenic variants in the caveolin-3 (CAV-3) gene.
- A comprehensive understanding of RMD's phenotypic spectrum is lacking.
Purpose of the Study:
- To systematically characterize the clinical, genetic, and pathological features of RMD.
- To investigate the phenotypic spectrum of RMD in Chinese families.
- To correlate CAV3 gene variants with CAV3 protein expression and RMD phenotypes.
Main Methods:
- Clinical data collection from 12 RMD patients across two families.
- Next-generation sequencing and Sanger sequencing for CAV3 gene variant analysis.
- Immunohistochemistry and western blotting to assess CAV3 protein expression.
- Literature review of previously reported RMD cases.
Main Results:
- All 12 patients exhibited childhood-onset exercise intolerance, muscle stiffness, and post-exercise myalgia.
- Percussion-induced muscle mounding and contractions were universally observed.
- A heterozygous c.80G>A (p.Arg27Gln) variant in the CAV3 gene was identified in all patients.
- Reduced CAV3 protein expression was detected in muscle tissue.
Conclusions:
- This study elucidates the clinical, electromyographical, and pathological characteristics of RMD in Chinese families.
- The findings expand the understanding of RMD's variable phenotypes.
- Genetic variants in CAV3 are confirmed as the cause of RMD, impacting protein expression.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Pleiotropy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Pedigree Analysis
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

